Latest Genome-wide association study Stories
A genetic variant implicated in several cancers by genome-wide association studies (GWAS) has been found to drive increased expression of a known oncogene in the prostate.
23andMe, Inc., a leading personal genetics company, announced today that it has published the first data to come out of its novel participant-driven research program.
A multi-institutional research team has found that rare variants in the gene coding an enzyme that controls the activity of a key immune cell occur more frequently in individuals with autoimmune disorders like rheumatoid arthritis and type 1 diabetes.
By investigating the association between genetic loci related to Alzheimer's disease and neuroimaging measures related to disease risk, researchers may have uncovered additional evidence that several previously studied genetic variants are associated with the development and progression of Alzheimer's disease and also may have identified new genetic risk factors for further study.
May spare side effects to those in whom treatment would be ineffective.
Genome Institute of Singapore and Sun Yat-Sen University Cancer Centre identify 3 new susceptibility genes in genome-wide association study of nasopharyngeal carcinoma.
While genome-wide association (GWA) studies have identified several genetic risk factors for common cancers, their predictive power is limited by their small effect sizes.
Although genome-wide analysis identified two genetic variations associated with Alzheimer disease (AD), these variations did not improve the ability to predict the risk of AD.
-- New Approach Also Specifies Results for Individual Patients -- PHILADELPHIA, April 29 /PRNewswire-USNewswire/ -- In findings that may speed the search for disease-causing genes, a new study challenges the prevailing view that common diseases are usually caused by common gene variants (mutations).
A large genetic study of age-related macular degeneration (AMD) has identified three new genes associated with this blinding eye diseaseâ€”two involved in the cholesterol pathway.
- The act of sweetening by admixture of some saccharine substance.